← Open Payments lookup

JESSICA DEINERT: Open Payments

NPI 1417312539 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,272 in 40 payments from 8 companies in 2025. Trend: 2023 $341 · 2024 $1,309 · 2025 $3,272

Consulting: $2,650Food & beverage: $622
CompanyPaymentsAmount
Janssen Biotech, Inc.2$1,768
AstraZeneca Pharmaceuticals LP1$900
Exelixis Inc.27$377
Bayer Healthcare Pharmaceuticals Inc.4$86
Eisai Inc.2$59
Merck Sharp & Dohme LLC2$49
Daiichi Sankyo Inc.1$20
PFIZER INC.1$14

Products named: ERLEADA, LYNPARZA, CABOMETYX, Nubeqa, Lenvima, KEYTRUDA, Enhertu, Xofigo.

Industry payments across TX — which companies pay providers there.